BACKGROUND

Guillain-Barré syndrome (GBS) is an acute inflammatory demyelinating polyneuropathy (AIDP)
usually presenting with proximal muscle weakness of lower extremities and sensory dysaesthesia, 2-4 weeks following a relatively benign respiratory and gastrointestinal illness. 1 The weakness can progress over days to involve arms, cranial nerves and respiratory muscles. Cranial nerve involvement has been reported in 45-75% of patients with GBS, with facial nerve involvement being the most common. Facial palsy is often bilateral, 2 and rarely unilateral. 3 We report a case of an adolescent girl who initially presented with a classical history of GBS and was making improvement; however, during the second week of illness, she developed unilateral facial palsy, which prolonged her illness; but she eventually made a good recovery. We discuss the literature review of unilateral facial palsy and GBS.
CASE PRESENTATION
A 15-year-old Caucasian girl presented with a 4-day history of progressive calf pain, and weakness in her distal lower and upper limbs. She had a history of acute diarrhoea and vomiting 2 weeks prior to the onset of symptoms, which had resolved after 7 days without any intervention. There were no other significant past medical problems, and no history of trauma.
On physical examination, cranial nerve function was normal. Fundus examination and otoscopy were unremarkable and there were no signs of bulbar weakness. Maximal lower limb weakness was reached by day 10 of admission, and after this, peripheral weakness improved gradually. On day 12, the patient developed facial asymmetry ( figure 1A ), left-sided complete facial weakness (figure 1B) and a watery left eye. She was diagnosed with unilateral left facial palsy. Examination of all other cranial nerves was normal and there was no discernible deterioration in peripheral motor function.
INVESTIGATIONS
Routine laboratory blood tests showed a normal full blood count with differential count, and normal renal and liver function tests. Vitamin B 12 and folate levels were within normal range, and the C reactive protein (CRP) was 9mg/L. Immunoglobulin studies revealed a raised IgM count of 3.13 g/L; IgG and IgA were within normal ranges. Antibodies to antiganglioside GM1 and GM2 were detected (>1000 titre) and blood serology demonstrated positive IgM titres for Campylobacter jejuni. Spirometry on admission showed normal respiratory function. Peak flow was measured twice daily. Initially, it was averaging around 420 L/min, however, by day 12-13, peak flow had decreased to approximately 390 L/min around the time the patient developed left facial weakness, which improved over the next few days along with peak flow.
Neuroimaging including CT brain scan and MRI spine scan showed no evidence of inflammation or demyelination.
Lumbar puncture for cerebrospinal fluid analysis was attempted but unsuccessful.
Nerve conduction velocity and electromyography (EMG) were performed on day 10 of symptom onset.
Sensory responses of the both, upper and lower limb nerves, were normal.
Motor responses of the right median nerve showed decreased amplitudes and conduction block at the forearm with slowing of the conduction velocity. The right ulnar, right tibial and right common peroneal nerves showed significantly reduced amplitudes with preserved conduction velocities. The right tibial nerve presented slightly prolonged distal latency.
The F-waves of the right tibial nerve were absent. The right median and right ulnar nerves showed prolonged latencies of the F-waves.
Needle EMG of the right hand muscles (extensor digitorum communis and first dorsal interosseus) showed moderate-to-severe reduced recruitment of fast firing motor units with no spontaneous activity indicating early axonal loss or proximal demyelination.
Conclusion: The findings were consistent with primary motor polyradiculoneuropathy with mixed axonal and demyelinating features, which, in correlation with the clinical history, was compatible with GBS.
DIFFERENTIAL DIAGNOSIS
Although unilateral facial palsy is very rare, care must be taken to exclude potential metabolic, infectious, vasculitic, immunological (multiple sclerosis), traumatic and neoplastic causes.
Lyme disease is also a common cause of facial palsy in endemic areas, but our patient had neither a history of exposure to ticks nor a history of recent travel. Nor did she have the typical erythaema chronicum migrans rash typically seen in patients with Lyme disease.
Multiple sclerosis was ruled out by absence of demyelinating lesions in neuroimaging of the head and spine.
The patient's presentation and normal imaging made central nervous system neoplastic lesions (acoustic neuromas, cerebellopontine angle tumours) and idiopathic intracranial hypertension unlikely, as patients with neoplastic lesions usually present with slowly progressive paralysis of facial nerves.
Ramsay Hunt syndrome must be considered in patients presenting with sudden onset of hearing loss and severe pain with onset of facial palsy. Typically these patients will have a vesicular rash involving the ear canal and auricle.
TREATMENT
The patient was treated with intravenous immunoglobulin (dose: 2 g/kg administered over 48 h) on days 4-5. Following this, she underwent intensive physiotherapy. Vital observations were performed every4 h, and peak flow was measured twice daily. When new left facial weakness developed, the patient was treated with a further course of immunoglobulin (on days [13] [14] . The second dose of immunoglobulin was given, as the patient responded well initially and her peripheral symptoms were improving, albeit very gradually.
OUTCOME AND FOLLOW-UP
The patient was admitted for a total of 33 days. During this time, her peripheral weakness gradually improved and on discharge she had reached a power of 4/5 in all lower limb muscle groups and a power of 4+/5 in all upper limb muscle groups. On discharge, she had some residual left-sided facial weakness, however, it was much improved.
On follow-up at 2 months following discharge, she had achieved complete recovery from her facial palsy. Power in her upper limbs was near normal with only slight weakness in hand grip bilaterally.
Lower limb power was near normal proximally and 4/5 distally at the ankles. Currently, at writing, the patient is fully mobile without any assistance although does use one crutch for longer distances as she gets tired. She still has a high stepping gait but no sensory involvement. Deep tendon reflexes are still absent at the ankles. She attends weekly physiotherapy sessions.
DISCUSSION
GBS is an acute-onset polyneuropathy mediated by an autoimmune response, commonly triggered by preceding viral or bacterial infection. 1 Cranial nerve palsies are frequently seen in GBS, however, unilateral facial palsy is rare and very few cases have been reported in the literature.
GBS has been known to present with bilateral facial nerve palsy, 2 and one recent report illustrates a 65-year-old patient who developed unilateral facial palsy simultaneously with lower limb weakness. 3 Our patient initially presented with lower limb weakness, and then progressed to develop left facial weakness approximately 2 weeks after initial onset of symptoms.
Another report described a middle-aged man who had unilateral facial palsy with evidence of multiple cranial nerve enhancements on MRI. 4 Sakakibara et al 5 described a middle-aged woman with axonal GBS who developed unilateral facial palsy along with 12th cranial nerve and phrenic palsy. Our index patient did not develop any other cranial nerve palsy and had no suggestion of phrenic palsy.
There are a limited number of paediatric GBS cases with unilateral facial palsy described in the literature. One report describes two children who developed unilateral facial nerve palsy in GBS complicated by hypertension. 6 Our patient was normotensive throughout admission and there was no evidence of autonomic dysfunction. A further recent report illustrated a 2-year-old boy with an acute sensorimotor axonal type of GBS after rotavirus gastroenteritis who developed unilateral facial palsy. 7 Another interesting point is the delayed onset of facial palsy in GBS. Our patient developed facial palsy in the second week of illness while her peripheral limb weakness started improving. There have been very few cases reported of delayed facial palsy in GBS in the paediatric population. The study by Tatsumoto et al 8 showed that 6% (n=12) of the patients developed delayed facial weakness and in those patients limb weakness did not progress any further, and the facial palsy improved without immunotherapy. Of these 12 patients, only 2 were under 18 years of age; the rest were adults. Delayed facial palsy has also been described in Miller Fisher syndrome, which is a variant of GBS, characterised by a triad of ophthalmoplaegia, ataxia and areflexia. Tan et al 9 and Kim et al 10 described delayed onset of facial palsy in Miller Fisher syndrome in adult populations. Interestingly, the study by Kim et al 10 showed no other cranial palsies apart from facial palsy developing as a delayed pattern. Most of the patients with delayed facial palsy had a good outcome within 1 month of follow-up.
In our case, the patient had a history of C. jejuni gastroenteritis 2 weeks prior to admission, which is the single most common antecedent infection associated with onset of GBS.
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The pathophysiology is thought to be an autoimmune response, whereby C. jejuni lipopolysaccharide cell surface proteins (similar to gangliosides) stimulate autoantibodies that then target peripheral nerves. 12 This 'ganglioside mimicry' appears to be important in determining the variant of GBS that manifests. In our patient, peripheral circulating anti-GM1/GM2 antibodies were detected, and electrodiagnostic studies showed axonal dysfunction, confirming that the patient had the acute motor axonal neuropathy (AMAN) variant of GBS as opposed to the more commonly encountered AIDP. 13 Anti-GM1 antibodies are more commonly associated with a purely motor variant of GBS, and are in fact less associated with cranial nerve involvement. 14 However, anti-GM2 with previous C. jejuni infection has been linked to bilateral facial paralysis, and may explain why our patient developed facial paralysis. 15 16 The presence of facial palsy in GBS has also been identified as a potential indicator for anticipating more complicated recovery, 17 and higher risk for mechanical ventilation, 18 however, this relates to bilateral facial palsy and the risk associated with unilateral weakness is unclear. In our patient, the onset of facial weakness coupled with slight reduction in peak-flow measurements alerted the team to potential deterioration in the patient's clinical course. We managed this patient with intravenous immunoglobulin initially, and gave a further course following onset of facial weakness.
Learning points
▸ Cranial nerve palsies are seen in almost half of the patients with Guillain-Barré syndrome. ▸ Although bilateral facial palsy is more commonly seen, unilateral facial palsy is a rare occurrence and can be seen in patients with Guillain-Barré syndrome. ▸ Paediatricians should be aware of the association of unilateral facial palsy and Guillain-Barré syndrome, as it can avoid misdiagnosis and unnecessary investigations. 
